5343-52-2

• 常用中文名：2-乙基-2-甲基戊酸
• 常用英文名：2-ETHYL-2-METHYLPENTANOIC ACID
• CAS号：5343-52-2
• 分子式：C₈H₁₆O₂
• 分子量：144.21100
• 发布时间：2018-09-16 10:33:29
• 更新时间：2026-07-11 08:45:04

名称

• 中文名: 2-乙基-2-甲基戊酸
• 英文名: 2-ethyl-2-methylpentanoic acid
• 中文别名: 丙戊酸杂质11(丙戊酸杂质K); 丙戊酸杂质K; 丙戊酸钠杂质12; VALPROIC ACID 杂质K; 丙戊酸钠杂质K; 帝拔癫杂质K; 2-甲基-2-乙基戊酸
• 英文别名: Valproic Acid Impurity 11(Valproic Acid Impurity K); Valporic acid Related Compound K; Valproic Acid IMpurity K; Pentanoic acid,2-ethyl-2-methyl; Valeric acid, 2-ethyl-2-methyl; EINECS 226-284-8; (2RS)-2-Ethyl-2-methylpentanoic acid; Valproic Acid Imp. K : (2RS)-2-ethyl-2-methylpentanoic acid; 2-Methyl-2-ethylpentanoic acid; 2-methyl-2-ethylpentanoic acid; Valproate Sodium Impurity 16; 2-ethyl-2-methyl-valericaci; Valproic Acid Impurity K (Valproic Acid Related Compound K); Sodium Valproate Impurity K; Einecs -8; 2-ethyl-2-methylvaleric acid; 2-ethyl-2-methyl valeric ccid; Valproic acid impurity 1; Valeric acid,2-ethyl-2-methyl; Valproic acid imp K; Nsc; Sodium Valproate Impurity 12

物化性质

• 密度: 0.928g/cm3
• 沸点: 227.7ºC at 760mmHg
• 分子式: C₈H₁₆O₂
• 分子量: 144.21100
• 闪点: 102.5ºC
• 精确质量: 144.11500
• PSA: 37.30000
• LogP: 2.28740
• 折射率: 1.62
• 储存条件: 2-8°C

毒性和生态

CHEMICAL IDENTIFICATION RTECS NUMBER : YV7391500 CHEMICAL NAME : Valeric acid, 2-ethyl-2-methyl- CAS REGISTRY NUMBER : 5343-52-2 LAST UPDATED : 198605 DATA ITEMS CITED : 2 MOLECULAR FORMULA : C8-H16-O2 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 390 mg/kg TOXIC EFFECTS : Behavioral - altered sleep time (including change in righting reflex) Behavioral - somnolence (general depressed activity) Behavioral - ataxia REFERENCE : NEPHBW Neuropharmacology. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.9- 1970- Volume(issue)/page/year: 24,427,1985 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 280 mg/kg TOXIC EFFECTS : Behavioral - altered sleep time (including change in righting reflex) Behavioral - somnolence (general depressed activity) Behavioral - ataxia REFERENCE : NEPHBW Neuropharmacology. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.9- 1970- Volume(issue)/page/year: 24,427,1985